APAC OTC Medications for Cough, Cold & Flu Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : February 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5043

  • Format: PPT, PDF

APAC OTC Medications for Cough, Cold & Flu Market Analysis: Segmented by Drug type, Treatment, Distribution Channel and Medical Devices – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5043 Categories: ,

Report Description of the OTC medication for Cough, Cold and Flu Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for OTC Medications for Cough, Cold & Flu Treatment Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the OTC Medications for Cough, Cold & Flu Treatment market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

APAC OTC Medications for Cough, Cold & Flu Market Executive Summary

Steadily increasing population in the APAC, particularly in countries like China, India, and Bangladesh, leading to high market penetration and boosting the growth of the OTC medications for cough, cold and flu market in the Asia Pacific. The growth propelling factors of the Asia-Pacific over-the-counter (OTC) drugs market are product innovations, high penetration in emerging countries, like India and China, and the inclination of pharmaceutical companies toward OTC drugs over prescription drugs. This can be attributed to the rapidly growing population and an increase in the disposable income of the population, which may add critical mass to the population available to access OTC medication.

Market Size and Key Findings

The APAC OTC Medications for Cough, Cold & Flu market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

APAC OTC Medications for Cough, Cold & Flu market is likely to grow at a remarkable rate during the forecast period.  Furthermore, many countries in South Asia-Pacific and Japan have a large number of the elderly population who are more prone to diseases. Thus, this factor is also likely to drive the OTC drugs market in the future.

Market Dynamics

Market Growth Drivers Analysis

The OTC medications for cough, cold, and flu market has been witnessing strong growth resulting from the rising demand from the consumers to self-medicate. In countries with high populations, such as China and India, the patients mostly rely on their neighborhood chemist to prescribe the appropriate medicines for illnesses, such as cough, cold, nasal congestion, or fever. In India, the frequency of certain ailments, like common colds and headaches, is significantly high and inconsistent across states. At the same time, consumers are becoming more prone to seeking OTC remedies and medicines rather than checking in with their physicians. In India, consumers are found to be dependent on OTC for cough, cold, or flu medicines, as these drugs are believed to offer instant relief. Owing to their easy procurement, the sales of OTC drugs for cough, cold, and flu have increased. Furthermore, many countries in South Asia-Pacific and Japan have a large number of the elderly population who are more prone to diseases. Thus, this factor is also likely to drive the OTC drugs market in the future.

Market Restraints

The lack of awareness among the population and incorrect self-diagnosis are expected to hamper the market growth.

COVID-19 impact on “APAC OTC Medications for Cough, Cold & Flu Market” 

Close to the beginning of 2021, COVID-19 disorder began to spread all through the planet, countless people in general were polluted with COVID-19 disease, and critical countries all through the planet have done foot limitations and work stoppage orders. Beside the clinical supplies and life support things organizations, most undertakings have been uncommonly impacted, and Cough and Cold Medicine adventures have been unbelievably affected.

Competitive Landscape

Key Players

Key companies profiled in the report include Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).

Products in Pipeline

The late-stage pipeline for seasonal influenza vaccines in the 3GM includes the first quadrivalent seasonal influenza vaccines in China from Sinovac, Chongqing Zhifei, and Wuhan, as well as a quadrivalent formulation of Fluad. Quadrivalent live-attenuated vaccines will launch in India (from the Serum Institute) and Japan (AstraZeneca’s FluMist, licensed by Daiichi Sankyo). Furthermore, two new inactivated quadrivalent vaccines from Biken and Denka Seiken will launch during the forecast period, as well as a novel plant-based influenza vaccine in Japan.

Notable Recent Deals

The U.S. Food and Drug Administration expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of flu for patients 12 years of age and older after contact with an individual who has the flu. Xofluza, previously available only in tablet form, is also now available as granules for mixing in water.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

WHO, through the WHO GISRS system, in collaboration with other partners, monitors influenza activity globally, recommends seasonal influenza vaccine compositions twice a year for the Northern and Southern hemisphere influenza seasons, guides countries in tropical and subtropical areas to choose vaccine formulations (Northern hemisphere vs. Southern hemisphere), to support decisions for timing of vaccination campaigns, and to support Member States to develop prevention and control strategies.

1. Report Description of the APAC OTC Medications for Cough, Cold & Flu Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC OTC Medications for Cough, Cold & Flu Market Executive Summary
2.1 APAC OTC cough, cold and flu market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC OTC Medications for Cough, Cold & Flu market
3.1 Market Growth Drivers Analysis
3.1.1 Raising demand from the consumers to self-medicate
3.1.2 Owing to easy procurement
3.1.3 Rising Geriatric population
3.2 Market Restraints Analysis
3.2.1 Lake of Awareness among the population
3.2.2 Incorrect self-diagnosis
3.3 Covid-19 Market Impact Analysis
3.3.1 Negative Impact on Outcomes
4. OTC Medications for Cough, Cold & Flu Treatment Market Segmentation
4.1 By Product Type Analysis:
4.1.1 Cough Suppressants
4.1.2 Combination Medicines
4.1.3 Expectorants
4.2 By Age Analysis:
4.2.1 Infants
4.2.2 Children
4.2.3 Adults
4.3 By Distribution Channel Analysis:
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies and Drug Stores
4.3.3 E- Pharmacies
4.4 By Medical Devices Analysis:
4.4.1 Digital Health Technology (Wearable Patch, smartphone based device)
4.4.2 Diagnostic tests
5. OTC Medications for Cough, Cold & Flu Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in OTC Medications for Cough, Cold & Flu Drugs Market
6.4 Notable recent deals in OTC Medications for Cough, Cold & Flu Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Pfizer, IncCompany overview
Product & Services, Strategies & Financials
7.2 Novartis AG Company overview
Product & Services, Strategies & Financials
7.3 Merck Group Company overview
Product & Services, Strategies & Financials
7.4 Johnson and Johnson Company overview
Product & Services, Strategies & Financials
7.5 GlaxoSmithKline PLC (GSK) Company overview
Product & Services, Strategies & Financials
7.6 The Procter and Gamble Company overview
Product & Services, Strategies & Financials
7.7 Reckitt Benckiser Group PLC Company overview
Product & Services, Strategies & Financials
7.8 Abbott Laboratories Company overview
Product & Services, Strategies & Financials
7.9 Accord Healthcare
Product & Services, Strategies & Financials
7.10 Sanofi Aventis
Product & Services, Strategies & Financials
7.11 Acella Pharmaceuticals
Product & Services, Strategies & Financials
7.12 Alora Pharmaceuticals
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of APAC OTC cough, cold and flumarket
9.2 Future Opportunities
10. Strategic Recommendations

APAC OTC Cough, Cold and Flu Market Segmentation

By Product:

Cough suppressants segment held the largest share in 2019, and is expected to maintain its dominance over the forecast period. This is attributed to commonly available dextromethorphan at chemist stores or pharmacies.

  • Cough Suppressants
  • Combination Medicines
  • Expectorants

By Age group:

By age group, the adult segment is expected to register the highest CAGR during the forecast period due to rising geriatric population and increasing respiratory illness among adults. Furthermore, it is also attributed to the fact that cough syrups are mainly recommended to the adult age group by the government whereas the pediatric age group cannot be provided with OTC cough syrups without any prescription.

  • Infants
  • Children
  • Adults

Distribution Type:

Based on the Based-on Distribution Channel, the market is bifurcated into Retail Pharmacies and Drug Stores, Hospital Pharmacies, and Others.

  • Retail Pharmacies and Drug Stores
  • Hospital Pharmacies
  • E-Pharmacy

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements